Clinical Trials Logo

Cytokine Release Syndrome clinical trials

View clinical trials related to Cytokine Release Syndrome.

Filter by:
  • Suspended  
  • Page 1

NCT ID: NCT04394182 Suspended - Pneumonia, Viral Clinical Trials

Ultra Low Doses of Therapy With Radiation Applicated to COVID-19

ULTRA-COVID
Start date: April 21, 2020
Phase: N/A
Study type: Interventional

The host response against the coronavirus 2 (SARS-CoV-2) appears to be mediated by a 'cytoquine storm' developing a systemic inflammatory mechanism and an acute respiratory distress syndrome (ARDS), in the form of a bilateral pneumonitis, requiring invasive mechanical ventilation (IMV) in an important group of patients. In terms of preventing progression to the critical phase with the consequent need of admission to the intensive care units (ICU), it has been recently proposed that this inflammatory cytoquine-mediated process can be safely treated by a single course of ultra-low radiotherapy (RT) dose < 1 Gy. The main purpose of the study was to analyze the efficacy of ultra low-dose pulmonary RT, as an anti-inflammatory intention in patients with SARS-Cov-2 pneumonia with a poor or no response to standard medical treatment and without IMV.